ArticleBMC research notes2025
Quantifying the potential gains in life expectancy from eliminating cardiovascular disease, road traffic injuries, and cancers in Iran.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundLife expectancy (LE) serves as a critical health metric for assessing changes in risk factors, health outcomes, and the effectiveness of medical treatments. This research sought to determine the impact of cardiovascular disease, road traffic accidents, and all types of cancer on the increase in Iranian life expectancy for the years 2010, and 2020.
methodInitial data on cardiovascular disease (CVD), all cancers, and road traffic injuries (RTI) by age, sex, and calendar year were obtained from the Iranian Death Registration System. Population data corresponding to these variables were retrieved from the Statistical Center of Iran. Finally, we utilized the period life table to estimate the effects of three mentioned causes of death on life expectancy increases. The data analysis was conducted using R software version 4.2.1.
resultsIn this study, excluding CVD increased life expectancy by 5.74 years for men and 10.62 years for women in 2010. In that calendar year, excluding deaths from RTIs increased life expectancy by 0.59 years for men and 0.24 years for women. Similarly, excluding cancer increased life expectancy by 1.31 years for men and 1.24 years for women. In 2020, excluding CVD increased life expectancy by 4.99 years for men and 9.66 years for women. Excluding road traffic injuries increased life expectancy by 0.46 years for men and 0.17 years for women. Excluding cancer increased life expectancy by 1.48 years for men and 1.39 years for women.
conclusionOur study found that at the national level, eliminating cardiovascular disease and then cancer had the greatest gain in life expectancy at birth and at other ages. Compared with the other two outcomes, the elimination of road traffic deaths had the smallest increase in life expectancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.